A pharmaceutically acceptable salt of pyrrolo [2,3,-b]pyridine compound as protein kinase inhibitor
PK201100646A0Undetermined Publication Date: 2011-09-21PLEXXIKON INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201100646
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2011-09-06
- Publication Date
- 2011-09-21
Abstract
A pharmaceutically acceptable salt of compound active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
Need to check novelty before this filing date? Find Prior Art